PROTOCOL SUMMARY FOR PATIENTS

View Professional Summary

Dasatinib in Treating Patients With Solid Tumor or Lymphoma That Are Metastatic or Cannot Be Removed By Surgery

Dasatinib in Treating Patients With Solid Tumor or Lymphoma That Are Metastatic or Cannot Be Removed By Surgery


Basic Trial Information

Protocol Phase:Phase I
Study Category:Treatment
Current Protocol StatusActive
Age18 and over
Protocol SponsorNCI
Primary IDNCI-2009-00792
Other IDNCT00608361
Special Category

TRIAL DESCRIPTION

Purpose:
Eligibility:
Treatment Intervention:
Patient Disclaimer: